The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
The 1D star will go ahead with his scheduled performance as per the wishes of his late mother, Johannah Deakin, who passed away on Friday.
Michael Gove admitted he made "mistakes" in his bid for the Tory Party leadership, and Theresa May was right to drop him from her cabinet.
Four people have been killed and at least 12 injured after a cargo train carrying propane-butane derailed and exploded in Bulgaria.